Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allium stent for treatment of ureteral stenosis.
Leonardo C, Salvitti M, Franco G, De Nunzio C, Tuderti G, Misuraca L, Sabatini I, De Dominicis C. Leonardo C, et al. Among authors: misuraca l. Minerva Urol Nefrol. 2013 Dec;65(4):277-83. Minerva Urol Nefrol. 2013. PMID: 24091480
Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European multicenter dataset.
Simone G, De Nunzio C, Ferriero M, Cindolo L, Brookman-May S, Papalia R, Sperduti I, Collura D, Leonardo C, Anceschi U, Tuderti G, Misuraca L, Dalpiaz O, Hatzl S, Lodde M, Trenti E, Pastore AL, Palleschi G, Lotrecchiano G, Salzano L, Carbone A, De Cobelli O, Tubaro A, Schips L, Zigeuner R, Tostain J, May M, Guaglianone S, Muto G, Gallucci M. Simone G, et al. Among authors: misuraca l. Eur J Surg Oncol. 2016 Nov;42(11):1729-1735. doi: 10.1016/j.ejso.2016.03.022. Epub 2016 Apr 12. Eur J Surg Oncol. 2016. PMID: 27106494
Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G, Tuderti G, Anceschi U, Papalia R, Ferriero M, Misuraca L, Minisola F, Mastroianni R, Costantini M, Guaglianone S, Sentinelli S, Gallucci M. Simone G, et al. Among authors: misuraca l. World J Urol. 2017 May;35(5):789-794. doi: 10.1007/s00345-016-1923-2. Epub 2016 Aug 30. World J Urol. 2017. PMID: 27578234
Papillary type 2 versus clear cell renal cell carcinoma: Survival outcomes.
Simone G, Tuderti G, Ferriero M, Papalia R, Misuraca L, Minisola F, Costantini M, Mastroianni R, Sentinelli S, Guaglianone S, Gallucci M. Simone G, et al. Among authors: misuraca l. Eur J Surg Oncol. 2016 Nov;42(11):1744-1750. doi: 10.1016/j.ejso.2016.08.003. Epub 2016 Aug 22. Eur J Surg Oncol. 2016. PMID: 27593224
Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: Results of a propensity score matched comparison with open cohort from a single-centre series.
Simone G, Tuderti G, Misuraca L, Anceschi U, Ferriero M, Minisola F, Guaglianone S, Gallucci M. Simone G, et al. Among authors: misuraca l. Eur J Surg Oncol. 2018 Sep;44(9):1432-1438. doi: 10.1016/j.ejso.2018.04.006. Epub 2018 Apr 17. Eur J Surg Oncol. 2018. PMID: 29699838 Clinical Trial.
Novel Diagnostic Biomarkers of Prostate Cancer: An Update.
Anceschi U, Tuderti G, Lugnani F, Biava PM, Malossini G, Luciani L, Cai T, Marsiliani D, Filianoti A, Mattevi D, Costantini M, Misuraca L, Simone G. Anceschi U, et al. Among authors: misuraca l. Curr Med Chem. 2019;26(6):1045-1058. doi: 10.2174/0929867325666180914115416. Curr Med Chem. 2019. PMID: 30215331
130 results